Company Filing History:
Years Active: 2025
Title: Huan Wang - Innovator in Pharmaceutical Therapy
Introduction
Huan Wang is a notable inventor based in Lianyungang, China. He has made significant contributions to the pharmaceutical field, particularly in the treatment of soft tissue sarcoma. His innovative approach combines quinoline derivatives with antibody therapies, showcasing his commitment to advancing medical science.
Latest Patents
Huan Wang holds a patent for a quinoline derivative and antibody soft tissue sarcoma combination therapy. This invention provides a therapeutically effective method for treating soft tissue sarcoma using a specific quinoline derivative compound I, known chemically as 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropylamine. This patent represents a significant advancement in cancer treatment options.
Career Highlights
Huan Wang is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His dedication to research and development has positioned him as a key figure in the industry.
Collaborations
Huan Wang collaborates with Di Wu, enhancing the research and development efforts within their organization. Their partnership exemplifies the importance of teamwork in driving innovation in the pharmaceutical sector.
Conclusion
Huan Wang's contributions to the field of pharmaceuticals, particularly through his patented combination therapy for soft tissue sarcoma, highlight his role as an influential inventor. His work continues to pave the way for new treatment options in cancer therapy.